Keenova Therapeutics plc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin 15
SEC filing record 1 source field available
Fiscal year end
31 December
Keenova Therapeutics plc has filed 1,440 SEC EDGAR filings since 01 Feb 2013

SEC filing history

Showing 726-750 of 1,000 matching filings.

Per page
25
Current page
30
4

PRIMARY DOCUMENT

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
14 Dec 2018
Reporting date
06 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Dec 2018
Reporting date
10 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35803

FORM 8-K

Filing date
06 Dec 2018
Reporting date
06 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35803

8-K 11.06.18

Filing date
06 Nov 2018
Reporting date
06 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87833

SC 13G

Filing date
12 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35803

8-K 08.07.18

Filing date
07 Aug 2018
Reporting date
07 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87833

SC 13G/A filing

Filing date
10 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jul 2018
Reporting date
01 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jul 2018
Reporting date
01 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jun 2018
Reporting date
01 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SD File 001-35803

SD

Filing date
31 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .